2000
DOI: 10.1128/mcb.20.19.7109-7120.2000
|View full text |Cite
|
Sign up to set email alerts
|

New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway

Abstract: Most, if not all, cytokines activate phosphatidylinositol 3-kinase (PI-3K). Although many cytokine receptors have direct binding sites for the p85 subunit of PI-3K, others, such as the interleukin-3 (IL-3) receptor beta common chain (␤c) and the IL-2 receptor beta chain (IL-2R␤), lack such sites, leaving the mechanism by which they activate PI-3K unclear. Here, we show that the protooncoprotein Shc, which promotes Ras activation by recruiting the Grb2-Sos complex in response to stimulation of cytokine stimulat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

15
267
2
1

Year Published

2002
2002
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 273 publications
(285 citation statements)
references
References 64 publications
15
267
2
1
Order By: Relevance
“…This finding is in keeping with recent data suggesting that Shc plays a role in promoting cell survival and counteracting apoptosis in response to cytokine receptors (Gu et al, 2000) and NGF receptor (Ulrich et al, 1998;Ashcroft et al, 1999) stimulation. The occurrence of apoptosis in our experimental system can be explained by several hypotheses: (1) Shc might transduce possible TRK-T3 anti-apoptotic signals; (2) signalling through tyrosine 317 of Shc could counteract a possible pro-apoptotic pathway induced by TRK-T3; (3) a pro-apoptotic signal might be the consequence of cell stress due to incorrectly transduced TRK-T3 signalling.…”
Section: Discussionsupporting
confidence: 92%
“…This finding is in keeping with recent data suggesting that Shc plays a role in promoting cell survival and counteracting apoptosis in response to cytokine receptors (Gu et al, 2000) and NGF receptor (Ulrich et al, 1998;Ashcroft et al, 1999) stimulation. The occurrence of apoptosis in our experimental system can be explained by several hypotheses: (1) Shc might transduce possible TRK-T3 anti-apoptotic signals; (2) signalling through tyrosine 317 of Shc could counteract a possible pro-apoptotic pathway induced by TRK-T3; (3) a pro-apoptotic signal might be the consequence of cell stress due to incorrectly transduced TRK-T3 signalling.…”
Section: Discussionsupporting
confidence: 92%
“…Many signaling pathways induce PI3K activation, although the level of PI3K activation and the downstream effector molecules vary depending on the signaling pathway. TCR cross-linking/ligation can activate PI3K, in part through Lck (39) and Gab2 adapter proteins (40). CD28 can directly activate PI3K through recruitment of p85 subunit (41).…”
Section: Discussionmentioning
confidence: 99%
“…Phosphorylation of only the second tyrosine would be predicted to create a high-affinity docking site for the Src homology 2-containing adapter protein Shc [20]. Recruitment of Shc may tie WC1 activation into the Ras-MAPK or the phosphatidylinositol 3-kinase/Akt pathways [32]. The YEEL motif in WC1 may also mediate WC1 endocytosis if the tyrosine is unphosphorylated [33]; although, we did not observe a change in the surface expression of WC1 when the tyrosine in the YEEL motif was mutated to phenylalanine.…”
mentioning
confidence: 99%